- Home
- MSC vs ABVX Comparison
MSC vs ABVX Comparison
Compare MSC & ABVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MSC
- ABVX
- Stock Information
- Founded
- MSC 2000
- ABVX 2013
- Country
- MSC Hong Kong
- ABVX France
- Employees
- MSC N/A
- ABVX N/A
- Industry
- MSC Hotels/Resorts
- ABVX
- Sector
- MSC Consumer Discretionary
- ABVX
- Exchange
- MSC Nasdaq
- ABVX Nasdaq
- Market Cap
- MSC 572.0M
- ABVX 511.3M
- IPO Year
- MSC 2018
- ABVX N/A
- Fundamental
- Price
- MSC $4.91
- ABVX $9.92
- Analyst Decision
- MSC
- ABVX Buy
- Analyst Count
- MSC 0
- ABVX 4
- Target Price
- MSC N/A
- ABVX $31.50
- AVG Volume (30 Days)
- MSC 11.9K
- ABVX 520.0K
- Earning Date
- MSC 08-12-2025
- ABVX 08-11-2025
- Dividend Yield
- MSC N/A
- ABVX N/A
- EPS Growth
- MSC N/A
- ABVX N/A
- EPS
- MSC N/A
- ABVX N/A
- Revenue
- MSC $650,708,000.00
- ABVX $11,444,012.00
- Revenue This Year
- MSC $8.92
- ABVX $284.20
- Revenue Next Year
- MSC N/A
- ABVX N/A
- P/E Ratio
- MSC N/A
- ABVX N/A
- Revenue Growth
- MSC 19.57
- ABVX 128.98
- 52 Week Low
- MSC $2.30
- ABVX $4.77
- 52 Week High
- MSC $9.30
- ABVX $13.35
- Technical
- Relative Strength Index (RSI)
- MSC 76.90
- ABVX 77.36
- Support Level
- MSC $4.05
- ABVX $7.70
- Resistance Level
- MSC $5.15
- ABVX $10.46
- Average True Range (ATR)
- MSC 0.39
- ABVX 0.54
- MACD
- MSC 0.06
- ABVX 0.25
- Stochastic Oscillator
- MSC 88.57
- ABVX 88.34
About MSC Studio City International Holdings Limited
Studio City International Holdings Ltd is a gaming, retail, and entertainment resort located in Cotai, Macau. It operates Studio City Casino with around 250 mass-market gaming tables; including tables for VIP rolling chip operations, and 552 gaming machines. Studio City features luxury hotel rooms, diverse food and beverage establishments, and complementary retail space. In addition, the company offers non-gaming attractions, including the world's first figure-8 Ferris wheel, a deluxe nightclub and karaoke venue, a live performance arena, an outdoor and an indoor water park. Geographically, the company derives the majority of its revenue from the Macau region.
About ABVX Abivax SA American
Abivax SA is a France-based clinical-stage biotechnology company focused on developing therapeutics that harness the body's natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases. Company is evaluating its drug candidate, obefazimod, in Phase 3 clinical trials for the treatment of adults with moderately to severely active ulcerative colitis. Its initial focus is on inflammatory bowel diseases, chronic conditions involving inflammation of the gastrointestinal tract, of which the two common forms are UC and CD.